As of 2026-04-04, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 18.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.42 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 454.1%.
The range of the Relative Valuation is 16.62 - 21.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 19.4x | 17.9x |
| Forward P/E multiples | 15.1x - 18.4x | 16.5x |
| Fair Price | 16.62 - 21.42 | 18.95 |
| Upside | 385.8% - 526.3% | 454.1% |
| Date | P/E |
| 2026-03-30 | 2.98 |
| 2026-03-27 | 3.00 |
| 2026-03-26 | 3.01 |
| 2026-03-25 | 3.18 |
| 2026-03-24 | 3.10 |
| 2026-03-23 | 3.22 |
| 2026-03-20 | 3.17 |
| 2026-03-19 | 3.28 |
| 2026-03-18 | 3.24 |
| 2026-03-17 | 3.28 |
| 2026-03-16 | 3.18 |
| 2026-03-13 | 3.11 |
| 2026-03-12 | 3.07 |
| 2026-03-11 | 3.09 |
| 2026-03-10 | 3.02 |
| 2026-03-09 | 2.96 |
| 2026-03-06 | 2.98 |
| 2026-03-05 | 3.09 |
| 2026-03-04 | 3.29 |
| 2026-03-03 | 3.07 |
| 2026-03-02 | 3.03 |
| 2026-02-27 | 3.10 |
| 2026-02-26 | 3.11 |
| 2026-02-25 | 3.39 |
| 2026-02-24 | 3.14 |
| 2026-02-23 | 3.00 |
| 2026-02-20 | 2.92 |
| 2026-02-19 | 2.88 |
| 2026-02-18 | 3.00 |
| 2026-02-17 | 2.90 |
| 2026-02-13 | 2.95 |
| 2026-02-12 | 2.88 |
| 2026-02-11 | 2.95 |
| 2026-02-10 | 3.07 |
| 2026-02-09 | 3.11 |
| 2026-02-06 | 3.09 |
| 2026-02-05 | 2.94 |
| 2026-02-04 | 3.10 |
| 2026-02-03 | 3.09 |
| 2026-02-02 | 3.09 |
| 2026-01-30 | 3.06 |
| 2026-01-29 | 3.10 |
| 2026-01-28 | 3.15 |
| 2026-01-27 | 3.16 |
| 2026-01-26 | 3.26 |
| 2026-01-23 | 3.08 |
| 2026-01-22 | 3.01 |
| 2026-01-21 | 3.12 |
| 2026-01-20 | 3.19 |
| 2026-01-16 | 3.34 |